Clinical Observation on 100 Cases of Male Immune Infertility Treated by Chinese Drugs

Sun Zhongming Bao Yanzhong

doi:10.13288/j.11-2166/r.2005.01.018

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on 100 Cases of Male Immune Infertility Treated by Chinese Drugs

更新时间：2021-11-20

- Clinical Observation on 100 Cases of Male Immune Infertility Treated by Chinese Drugs
- Journal of Traditional Chinese Medicine Issue 1, Pages: 36-37(2005)
- 作者机构：
  
  1. 浙江省中西医结合医院生殖医学科
  2. 浙江省中西医结合医院生殖医学科杭州市环城东路208号,310003
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2005.01.018
  CLC： R256.5
- Published：2005
- 稿件说明：
移动端阅览
[1]孙中明,鲍严钟.中药治疗男性免疫性不育100例临床观察[J].中医杂志,2005(01):36-37.

Sun Zhongming Bao Yanzhong. Clinical Observation on 100 Cases of Male Immune Infertility Treated by Chinese Drugs[J]. Journal of Traditional Chinese Medicine2005, (1): 36-37.
[1]孙中明,鲍严钟.中药治疗男性免疫性不育100例临床观察[J].中医杂志,2005(01):36-37. DOI： 10.13288/j.11-2166/r.2005.01.018.

Sun Zhongming Bao Yanzhong. Clinical Observation on 100 Cases of Male Immune Infertility Treated by Chinese Drugs[J]. Journal of Traditional Chinese Medicine2005, (1): 36-37. DOI： 10.13288/j.11-2166/r.2005.01.018.

摘要

目的:观察中药益抗汤治疗男性免疫性不育的疗效。方法:以中药益抗汤治疗男性免疫性不育100例

并与强的松组100例作对照

治疗前后分别作精液分析、血清或精浆抗精子抗体（AsAb）、支原体检测和培养、前列腺常规和体检。结果:（1）两组治疗后均可明显降低血清和精浆 AsAb 的水平（P<0.01）

但中药益抗汤组更显著。（2）治疗后两组患者的精子密度、活动率均有所提高（P<0.01）

但中药益抗汤组更显著

且妻子妊娠率也显著高于强的松组（P<0.01）。（3）治疗后两组精子凝集率均显著降低

其中益抗汤组更显著。（4）益抗汤组症状改善率及停药后疗效稳定性较强的松组更佳（P<0.01）。结论:中药益抗汤治疗男性免疫性不育疗效优于西药强的松组。

Abstract

Objective:To observe therapeutic effect of Chinese drugs Yikang Decoction on male immune infertility.Methods:100 cases of male immune infertility were treated with Yikang Decoction（treatment group）and other 100 cases with prednisone as controls. Analysis of seminal fluid

detection of anti-sperm antihody（AsAb）and mycoplasma in serum and seminal plasma

and culture of mycoplasma

routine examination of prostate gland and physical examination were carried out.Results:（1）After treatment

AsAb level in serum and seminal plasma increased significantly in the two groups（P<0.01）

with more significant increase in the treatment group.（2）After treatment

the sperm density and percentage of motile spermatozoa increased significantly（P<0.01）in the two groups

with more increase in the treatment group.The pregnancy rate of their wives in the treatment group was higher than that in the control group（P<0.01）.（3）After treatment

the sperm agglutination rate in the two groups decreased significantly

with more significant decrease in the treatment group.（4）The improving rate of symptoms and the stability of therapeutic effect after ceasing of drugs in the treatment group was better than that in the control group（P<0.01）.Conclusion: Therapeutic effect of Yikang Decoction on male immune infertility is better than that of prednisone

with stable therapeutic effect.

关键词

Keywords

references

查看原文

Views

152

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Shengjing-Infusion on Sperm Morphology in Sterility Cases with Varicocele

Clinical Observation on No.2 Guominkang Capsules for Treatment of 42 Cases of Male Immune Infertility

Effect of Tongbian Decoction （通便汤） on the VAPB-PTPIP51 Complex and Autophagy of Interstitial Cells of Cajal in the Colon of Slow Transit Constipation Model Rats

Exploring the Comorbidity Mechanism，Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory

A Preliminary Discussion on the Method of Regulating Qi and Calming the Mind

Related Author

安立文

王树林

白贵林

刘胜利

郁荫德

王琦

骆庆峰

赵厚薇

Related Institution

黑龙江中医药大学附属第一医院

黑龙江中医药大学附属第一医院黑龙江省哈尔滨市动力区

北京中医药大学

中华中医药学会

北京中西男科医药有限公司北京市朝阳区北三环东路11号

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰